Skip to Main Content

Talk about playing favorites.

A small drug company called TherapeuticsMD (TXMD) agreed to pay $200,000 to settle charges of illegally sharing material, non-public information with analysts after holding discussions with the Food and Drug Administration about a key medicine being developed.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!